Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05642884 · ClinicalTrials.gov registry record · NA
Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
A NA study of Multiple Myeloma, sponsored by Noha Mohamed Sharafeldin.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05642884: Recruiting NA study of Multiple Myeloma, sponsored by Noha Mohamed Sharafeldin.
NCT05642884 is a NA study of Multiple Myeloma that is actively recruiting participants, run by Noha Mohamed Sharafeldin. The registered enrollment target is 30 participants, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05642884, a NA study of Multiple Myeloma, is actively recruiting participants, sponsored by Noha Mohamed Sharafeldin.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and secondary outcomes include changes in physical function at the time of transplant and at 12 weeks follow up.
Primary Outcome
Participation rate will be measured as the number of participants agreeing to participate in the study divided by total participants approached for the study.
Conditions Studied
Interventions
- OTHER Multi-modal Exercise Regimen
- BEHAVIORAL Dietary Guidelines
Study Locations (1)
Alabama
- Kirklin Clinic of UAB Hospital - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-07-10 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05642884 shows while recruiting
NCT05642884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 2 interventions - of which Multi-modal Exercise Regimen is the first listed.
NCT05642884 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05642884 about?
NCT05642884 is a clinical study titled "Prehabilitation Feasibility Among Older Adults Undergoing Transplantation". This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and seco...
What is the current status of trial NCT05642884?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-07-10. Estimated completion is 2026-12-31.
What conditions does trial NCT05642884 study?
This clinical trial studies the following conditions: Multiple Myeloma.
What interventions are being tested in trial NCT05642884?
The interventions under investigation include: Multi-modal Exercise Regimen (OTHER), Dietary Guidelines (BEHAVIORAL).
Who is sponsoring clinical trial NCT05642884?
This trial is sponsored by Noha Mohamed Sharafeldin, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05642884 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05642884's enrollment target sits among peer trials
30 338th of 438 higher than 80 of 438 other Multiple Myeloma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Myeloma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
RECRUITING · NA
-
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
-
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI